Tharimmune, Inc. (THAR)
NASDAQ: THAR · IEX Real-Time Price · USD
3.741
-0.019 (-0.52%)
At close: Jul 19, 2024, 4:00 PM
3.650
-0.091 (-2.42%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $4.10 million as of July 22, 2024. Its market cap has decreased by -37.93% in one year.
Market Cap
4.10M
Enterprise Value
-4.01M
1-Year Change
-37.93%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $4.10M, a decrease of -90.05%. That is a compound annual growth rate of -60.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.90M | 625.00% |
| Dec 29, 2023 | 400.00K | -91.11% |
| Dec 30, 2022 | 4.50M | -89.07% |
| Jan 12, 2022 | 41.18M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hoth Therapeutics | 4.41M |
| Trevena | 4.37M |
| Allarity Therapeutics | 4.30M |
| MyMD Pharmaceuticals | 4.25M |
| CERo Therapeutics Holdings | 4.17M |
| OpGen | 4.08M |
| Genprex | 4.07M |
| Palisade Bio | 4.05M |